or
forgot password
  • cancer clinical trials in baltimore, MD

  • A Phase I, Open-Label, First-Time-In-Human Study of the Oral AKT Inhibitor GSK2141795
    GSK Investigational Site
    Baltimore, Maryland 21201
    Cancer
    Image-Guided Radiosurgery or Stereotactic Body Radiation Therapy in Treating Patients With Localized Spine Metastasis
    St. Agnes Hospital Cancer Center
    Baltimore, Maryland 21229
    Metastatic Cancer, Pain
    A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
    Research Site
    Baltimore, Maryland
    Cancer, Cataract, Low Bone Mineral Density, Osteopenia, Osteoporosis, Prostate Cancer
    An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab
    University of Maryland, Maryland Center for MS
    Baltimore, Maryland
    Multiple Sclerosis, Relapsing-Remitting
    Tadalafil in Preventing Erectile Dysfunction in Patients With Prostate Cancer Treated With Radiation Therapy
    Greenebaum Cancer Center at University of Maryland Medical Center

    Trial Locations
    Greenebaum Cancer Center at University of Maryland Medical Center
    St. Agnes Hospital Cancer Center
    Prostate Cancer, Sexual Dysfunction
    Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer
    Greenebaum Cancer Center at University of Maryland Medical Center

    Trial Locations
    Greenebaum Cancer Center at University of Maryland Medical Center
    Greater Baltimore Medical Center Cancer Center
    St. Agnes Hospital Cancer Center
    Prostate Cancer
    Analysis of Surgery in Patients Presenting With Stage IV Breast Cancer
    John Hopkins Medical Center
    Baltimore, Maryland 21287
    Breast Cancer
    Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
    Johns Hopkins University

    Trial Locations
    Johns Hopkins University
    University of Maryland Greenebaum Cancer Center
    Veterans Administration Medical Center
    Distal Urethral Cancer, Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter, Proximal Urethral Cancer, Recurrent Bladder Cancer, Recurrent Prostate Cancer, Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter, Recurrent Urethral Cancer, Stage IV Bladder Cancer, Stage IV Prostate Cancer, Transitional Cell Carcinoma of the Bladder, Urethral Cancer Associated With Invasive Bladder Cancer
    Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endometrial Cancer
    Alvin and Lois Lapidus Cancer Institute at Sinai Hospital

    Trial Locations
    Alvin and Lois Lapidus Cancer Institute at Sinai Hospital
    Greater Baltimore Medical Center Cancer Center
    St. Agnes Hospital Cancer Center
    Endometrial Cancer
    Combination Chemotherapy and Surgery in Treating Young Patients With Wilms Tumor
    University of Maryland Greenebaum Cancer Center
    Baltimore, Maryland 21201
    Diffuse Hyperplastic Perilobar Nephroblastomatosis, Rhabdoid Tumor of the Kidney, Stage I Wilms Tumor, Stage II Wilms Tumor, Stage III Wilms Tumor, Stage IV Wilms Tumor, Stage V Wilms Tumor
    Optimized Donor Selection, Nonmyeloablative BMT for B-cell Lymphomas With Post-transplantation Cy and Rituximab
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
    Baltimore, Maryland 21231-2410
    Lymphoma, B-cell Lymphoma, Non Hodgkin Lymphoma, Chronic Lymphocytic Leukemia
    S0819: Carboplatin/Paclitaxel With or Without Bevacizumab and/or Cetuximab in Stage IV or Recurrent Non-Small Cell Lung Cancer
    Alvin and Lois Lapidus Cancer Institute at Sinai Hospital

    Trial Locations
    Alvin and Lois Lapidus Cancer Institute at Sinai Hospital
    Mercy Medical Center
    Lung Cancer
    Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    Sinai Hospital of Baltimore

    Trial Locations
    Sinai Hospital of Baltimore
    Franklin Square Hospital Center
    Greater Baltimore Medical Center
    Brenner Tumor, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Stage IIA Fallopian Tube Cancer, Stage IIA Ovarian Epithelial Cancer, Stage IIA Primary Peritoneal Cavity Cancer, Stage IIB Fallopian Tube Cancer, Stage IIB Ovarian Epithelial Cancer, Stage IIB Primary Peritoneal Cavity Cancer, Stage IIC Fallopian Tube Cancer, Stage IIC Ovarian Epithelial Cancer, Stage IIC Primary Peritoneal Cavity Cancer, Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Epithelial Cancer, Stage IIIA Primary Peritoneal Cavity Cancer, Stage IIIB Fallopian Tube Cancer, Stage IIIB Ovarian Epithelial Cancer, Stage IIIB Primary Peritoneal Cavity Cancer, Stage IIIC Fallopian Tube Cancer, Stage IIIC Ovarian Epithelial Cancer, Stage IIIC Primary Peritoneal Cavity Cancer, Stage IV Fallopian Tube Cancer, Stage IV Ovarian Epithelial Cancer, Stage IV Primary Peritoneal Cavity Cancer
    Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed Persistent or Recurrent Uterine or Ovarian Cancer
    Alvin and Lois Lapidus Cancer Institute at Sinai Hospital

    Trial Locations
    Alvin and Lois Lapidus Cancer Institute at Sinai Hospital
    Greater Baltimore Medical Center Cancer Center
    Ovarian Cancer, Sarcoma
    Smoking Cessation for Veterans With Severe and Persistent Mental Illness
    Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD
    Baltimore, Maryland 21201
    Schizoaffective Disorder, Schizophrenia, Mood Disorders With Psychotic Features
    Tarceva With Chemoradiation and Adjuvant Chemotherapy for Resectable Pancreatic Cancer
    The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
    Baltimore, Maryland 21231
    Pancreatic Cancer
    Trial Comparing the Use of FLT PET to Standard CT to Assess Treatment Response of Neoadjuvant Docetaxel and Cisplatin in Stage IB-IIIA Resectable NSCLC
    Johns Hopkins University
    Baltimore, Maryland 21205
    Recurrent Non-small Cell Lung Cancer, Stage IB Non-small Cell Lung Cancer, Stage IIA Non-small Cell Lung Cancer, Stage IIB Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    A Phase 1/2 Study of the HSP90 Inhibitor, STA-9090 in Subjects With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Blast-phase Chronic Myelogenous Leukemia
    Kimmel Comprehensive Cancer Center at Johns Hopkins University
    Baltimore, Maryland 21231
    Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Blastic Phase Chronic Myelogenous Leukemia, CML
    PRostate Cancer Individual Signature Evaluation Trial in Patients Undergoing Scheduled Prostate Biopsy
    Johns Hopkins University Brady Urological Institute
    Baltimore, Maryland 21287
    Prostate Cancer
    Continued HER2 Suppression With Lapatinib Plus Trastuzumab Versus Trastuzumab Alone
    GSK Investigational Site
    Baltimore, Maryland 21201
    Cancer
    Cyclophosphamide and Vaccine Therapy With or Without Trastuzumab in Treating Patients With Metastatic Breast Cancer
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
    Baltimore, Maryland 21231-2410
    Breast Cancer
    Investigation of Genetic Determinants of Capecitabine Toxicity
    Johns Hopkins
    Baltimore, Maryland 21231
    Breast Cancer
    Erlotinib With or Without Hydroxychloroquine in Chemo-Naive Advanced NSCLC and (EGFR) Mutations
    University of Maryland
    Baltimore, Maryland 21201
    Non-small Cell Lung Cancer
    Paclitaxel, Carboplatin, and Bevacizumab or Paclitaxel, Carboplatin, and Temsirolimus or Ixabepilone, Carboplatin, and Bevacizumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer
    Sinai Hospital of Baltimore

    Trial Locations
    Sinai Hospital of Baltimore
    Franklin Square Hospital Center
    Greater Baltimore Medical Center
    Endometrial Adenocarcinoma, Endometrial Adenosquamous Cell Carcinoma, Endometrial Clear Cell Carcinoma, Recurrent Endometrial Carcinoma, Stage III Endometrial Carcinoma, Stage IV Endometrial Carcinoma
    Chemotherapy and Radiation Therapy With or Without Panitumumab in Treating Patients With Stage IIIA Non-Small Cell Lung Cancer (Cetuximab Closed as of 05/14/10)
    Greenebaum Cancer Center at University of Maryland Medical Center

    Trial Locations
    Greenebaum Cancer Center at University of Maryland Medical Center
    St. Agnes Hospital Cancer Center
    Lung Cancer
    GDC-0449 in Treating Patients With Recurrent Glioblastoma Multiforme That Can Be Removed by Surgery
    Adult Brain Tumor Consortium
    Baltimore, Maryland 21231-1000
    Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, Recurrent Adult Brain Tumor
    Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Liver Cancer
    Sinai Hospital of Baltimore
    Baltimore, Maryland 21225
    Childhood Hepatoblastoma, Stage I Childhood Liver Cancer, Stage II Childhood Liver Cancer, Stage III Childhood Liver Cancer, Stage IV Childhood Liver Cancer
    Chemotherapy and Pelvic Radiation Therapy With or Without Additional Chemotherapy in Treating Patients With High-Risk Early-Stage Cervical Cancer After Radical Hysterectomy
    Greenebaum Cancer Center at University of Maryland Medical Center

    Trial Locations
    Greenebaum Cancer Center at University of Maryland Medical Center
    Greater Baltimore Medical Center Cancer Center
    Cervical Cancer
    Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL
    Johns Hopkins University
    Baltimore, Maryland 21205
    Relapsed T-Cell Acute Lymphoblastic Leukemia, Relapsed T-Cell Lymphoblastic Lymphoma
    Study to Evaluate the Effect of Sulforaphane in Broccoli Sprout Extract on Breast Tissue
    Johns Hopkins Medical Institution
    Baltimore, Maryland 21205
    Breast Cancer
    Therapeutic Vaccination for Patients With HPV16+ Cervical Intraepithelial Neoplasia (CIN2/3)
    Johns Hopkins Outpatient Center

    Trial Locations
    Johns Hopkins Outpatient Center
    Johns Hopkins Bayview Medical Center
    HPV16+, Cervical Intraepithelial Neoplasia (CIN 2/3)
    Carboplatin, Paclitaxel, Bevacizumab, and ABT-888 in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    Johns Hopkins University
    Baltimore, Maryland 21205
    Brenner Tumor, Ovarian Carcinosarcoma, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Stage IIA Fallopian Tube Cancer, Stage IIA Ovarian Epithelial Cancer, Stage IIA Primary Peritoneal Cavity Cancer, Stage IIB Fallopian Tube Cancer, Stage IIB Ovarian Epithelial Cancer, Stage IIB Primary Peritoneal Cavity Cancer, Stage IIC Fallopian Tube Cancer, Stage IIC Ovarian Epithelial Cancer, Stage IIC Primary Peritoneal Cavity Cancer, Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Epithelial Cancer, Stage IIIA Primary Peritoneal Cavity Cancer, Stage IIIB Fallopian Tube Cancer, Stage IIIB Ovarian Epithelial Cancer, Stage IIIB Primary Peritoneal Cavity Cancer, Stage IIIC Fallopian Tube Cancer, Stage IIIC Ovarian Epithelial Cancer, Stage IIIC Primary Peritoneal Cavity Cancer, Stage IV Fallopian Tube Cancer, Stage IV Ovarian Epithelial Cancer, Stage IV Primary Peritoneal Cavity Cancer